Emmerson's Nonexecutive Chairman Steps Down, Successor Named
Published on 10/28/2024 at 05:25, updated on 10/28/2024 at 05:26

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.950 GBX | 0.00% |
|
0.00% | +219.67% |
May. 01 | Emmerson Files Arbitration Claim Against Morocco Over Potash Project | MT |
May. 01 | AIM WINNERS & LOSERS: Mirriad Advertising "urgently" seeking funds | AN |
Published on 10/28/2024 at 05:25, updated on 10/28/2024 at 05:26
Presently, James Patrick Kelly holds the position of Chief Financial Officer, Treasurer & Executive VP of Novavax, Inc. He is also Member of The Association of Bioscience Financial Officers. In his past career he held the position of Chief Financial Officer, Treasurer & Executive VP for Vanda Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President at Supernus Pharmaceuticals, Inc., Director-Planning & Operations at Biogen, Inc., Principal at Aetna, Inc. and Vice President & Controller for MedImmune LLC. Mr. Kelly received an MBA from Cornell University and an undergraduate degree from the University of Vermont.
View full profileSelect your edition
All financial news and data tailored to specific country editions